Luxottica Group S.p.A. (ADR) 

(Public, NYSE:LUX)   Watch this stock   
Find more results for LUX
Oct 30, 2009
Shareholders Meeting (Second call)
Oct 29, 2009
Q3 2009 Earnings Conference Call - Webcast
Oct 29, 2009
Q3 2009 Earnings Release
Oct 29, 2009
Shareholders Meeting (First call)
More events from AOL Finance »    

Key stats and ratios

Q3 (Sep '09) 2008
Net profit margin 6.96% 7.60%
Operating margin 11.74% 14.41%
EBITD margin - 19.51%
Return on average assets 4.79% 5.47%
Return on average equity 12.01% 15.18%
Employees 61,000 -

Address

Via Cantu 2
Milan, 20123
Italy
+39-02-863341 (Phone)
+39-02-86334092 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance

Luxottica Group S.p.A. (ADR) discussions

  View all discussions »

Description

Luxottica Group S.p.A. (Luxottica Group) is engaged in the designing, manufacturing and distribution of fashion, luxury and sports eyewear. Luxottica Group operates in two industry segments: manufacturing and wholesale distribution, and retail distribution. Through its manufacturing and wholesale distribution operations, Luxottica Group is engaged in the design, manufacturing, wholesale distribution and marketing of house and designer lines of prescription frames and sunglasses. The Company operates its retail segment principally through its retail brands, which include, among others, LensCrafters, Sunglass Hut, Pearle Vision, ILORI, The Optical Shop of Aspen, OPSM, Laubman & Pank, Budget Eyewear, Bright Eyes, Oakley O Stores and Vaults, David Clulow and its licensed Brands (Sears Optical and Target Optical). During the year ended December 31, 2008, it manufactured approximately 50.1 million prescription frames and sunglasses.

Officers and directors

Leonardo Del Vecchio
Executive Chairman of the Board
Portrait. Age: 74
Bio & Compensation - Reuters
Andrea Guerra
Chief Executive Officer, Director
Bio & Compensation - Reuters
Luigi Francavilla
Executive Vice Chairman of the Board
Bio & Compensation - Reuters
Enrico Cavatorta
Chief Financial Officer, Executive Director
Bio & Compensation - Reuters
Mario Cattaneo
Independent Director
Bio & Compensation - Reuters
Claudio Del Vecchio
Non-Executive Director
Bio & Compensation - Reuters
Roberto Chemello
Non-Executive Director
Age: 55
Bio & Compensation - Reuters
Sabina Grossi
Non-Executive Director
Bio & Compensation - Reuters
Sergio Erede
Non-Executive Director
Age: 68
Bio & Compensation - Reuters